Test for the quantitative determination of human antibodies of the immunoglobulin class A against β2-glycoprotein I (β2-GP1), to support the diagnosis of antiphospholipid syndrome (APS).
Test for the determination of human antibodies of the immunoglobulin class G against smooth-muscle cytoplasmatic antigens (ASMA), to support the diagnosis of autoimmune liver diseases, particularly autoimmune hepatitis (AIH).
Test for the determination of human antibodies of the immunoglobulin class G against Saccharomyces cerevisiae (ASCA), to support the diagnosis of chronic inflammatory bowel diseases (IBD).
Test for the determination of human antibodies of the immunoglobulin class G against anti-nuclear autoantibodies (ANA), to support the diagnosis of systemic autoimmune rheumatic diseases (SARD).
Test for the determination of human antibodies of the immunoglobulin class G against various epitopes of the inner mitochondrial membrane (AMA-M2, -M2-3E, -M4, -M9), to support the diagnosis of autoimmune liver diseases, and specifically primary biliary cholangitis (PBC).
Test for the determination of human antibodies of the immunoglobulin class G against inner mitochondrial membrane antigens (AMA), to support the diagnosis of autoimmune liver diseases, particularly primary biliary cholangitis (PBC).
Test for the determination of human antibodies of the immunoglobulin class G against the protein thrombospondin type-1 domain-containing 7A (THSD7A), to support the diagnosis of primary membranous nephropathy (pMN).
Test for the determination of human antibodies of the immunoglobulin class G against type VII collagen, to support the diagnosis of epidermolysis bullosa acquisita (EBA) and its differentiation from other autoimmune blistering diseases.
Subscribe to our newsletter to be always updated.